Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06601569

Predictors of Range of Motion and Balance Abnormalities in Children Diagnosed with Cerebral Palsy

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Months – 5 Years
Healthy volunteers
Not accepted

Summary

1. To better understand the factors that contribute to ROM abnormalities in children diagnosed with CP. 2. To describe the distribution of primary (muscle tone and postural stability)and secondary impairments (ROM and functional muscle strength) across the gross motor spectrum measured by GMFCS scores. 3. To evaluate the effects of primary and secondary impairments on gross functional outcome in children with spastic CP. 4. To find any possible correlation between clinical variables.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTbalance and range of motion* Spinal alignment and range of motion measure scale (SAROMM): is a measure of spinal alignment and range of motion using standard physical therapy techniques scored on a 5-point ordinal score of 0 (normal alignment and range with active correction) to4 ("severe" fixed deformity) (Bartlett ey al., 2005) * Modified Ashworth scale (MAS): is a measure of muscle motion and scoring the perceived resistance to movement on a scale of 1 (no increase in tone) to 5 (rigid in flexion or extension) (Clopton et al., 2005). * Early clinical assessment of balance (ECAB) scale: Is a 13-item test that estimates postural stability for children with CP across all levels of functional ability (Jeffries etal., 2016). * Functional strength assessment scale: Therapists completed a functional strength assessment (FSA) to obtain an estimate of strength for major muscle groups including the neck and trunk flexors and extensors, and hip extensors, knee extensors, and shoulder flexors bilaterally.

Timeline

Start date
2024-08-01
Primary completion
2025-01-01
Completion
2025-02-01
First posted
2024-09-19
Last updated
2024-10-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06601569. Inclusion in this directory is not an endorsement.